Quantifying the Health and Productivity Burden of Migraine Among Working-Age Women in Western Europe, 2023-2029: A Global Burden of Disease Study 2023 Analysis.

Migraine is a major health issue affecting many women in Western Europe. This study focused on women aged 20-64 years from 2023 to 2029. Researchers aimed to measure the health and productivity impact of migraines. They used advanced statistical methods to analyze existing data. The study estimated significant losses in disability-adjusted life years (DALYs) and productivity-adjusted life years (PALYs). From 2023 to 2029, the total DALYs lost reached 10.867 million. Additionally, about 1.082 million PALYs were estimated to be lost. The financial impact of these losses was substantial, totaling Int$69.85 billion. This amount reflects the economic burden of migraines on society. Belgium had the highest estimated burden among the countries studied. Overall, migraines significantly affect women's health and productivity in Western Europe. Addressing this issue is crucial for improving quality of life and economic outcomes for affected individuals. Clinical relevance: This research highlights the significant economic burden of migraines on working-age women, emphasizing the need for better treatment options and support in the workplace.